Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated α-synuclein mouse model of Parkinson’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Neurobiology of Disease 2022, 171:105798. DOI: 10.1016/j.nbd.2022.105798
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2023
- Urheber
-
Rauschenberger, Lisa
Behnke, Jennifer
Grotemeyer, Alexander
Knorr, Susanne
Volkmann, Jens
Ip, Chi Wang
- DOI
-
10.1016/j.nbd.2022.105798
- URN
-
urn:nbn:de:bvb:20-opus-300629
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:44 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rauschenberger, Lisa
- Behnke, Jennifer
- Grotemeyer, Alexander
- Knorr, Susanne
- Volkmann, Jens
- Ip, Chi Wang
- Universität Würzburg
Entstanden
- 2023
Ähnliche Objekte (12)
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Modeling Neuroinflammation in sporadic Parkinson ́s disease
Neuroinflammation in Parkinson’s disease – putative pathomechanisms and targets for disease-modification
Emotional behavior of aged A53T α-Synuclein Parkinson mice
Novel immunotherapeutic approaches to target alpha-synuclein and related neuroinflammation in Parkinson’s disease
Neuroinvasion and cerebral ischemia as possible sources for α-synuclein prions in Parkinson’s disease
Increased immune activation by pathologic α‐synuclein in parkinson's disease
Increased immune activation by pathologic α‐synuclein in Parkinson's disease
Cross-talk between α-synuclein post-translational modifications in yeast as model of Parkinson’s disease
Investigating the interplay between α-Synuclein and fragile X mental retardation protein in Parkinson’s disease
C-terminal tyrosine residue modifications modulate α-synuclein toxicity in yeast as unicellular model for Parkinson´s disease
α-Synuclein in parkinson's disease: pathogenic function and translation into animal models
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Modeling Neuroinflammation in sporadic Parkinson ́s disease
Neuroinflammation in Parkinson’s disease – putative pathomechanisms and targets for disease-modification
Emotional behavior of aged A53T α-Synuclein Parkinson mice
Novel immunotherapeutic approaches to target alpha-synuclein and related neuroinflammation in Parkinson’s disease
Neuroinvasion and cerebral ischemia as possible sources for α-synuclein prions in Parkinson’s disease
Increased immune activation by pathologic α‐synuclein in parkinson's disease
Increased immune activation by pathologic α‐synuclein in Parkinson's disease
Cross-talk between α-synuclein post-translational modifications in yeast as model of Parkinson’s disease
Investigating the interplay between α-Synuclein and fragile X mental retardation protein in Parkinson’s disease
C-terminal tyrosine residue modifications modulate α-synuclein toxicity in yeast as unicellular model for Parkinson´s disease
α-Synuclein in parkinson's disease: pathogenic function and translation into animal models
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Modeling Neuroinflammation in sporadic Parkinson ́s disease
Neuroinflammation in Parkinson’s disease – putative pathomechanisms and targets for disease-modification
Emotional behavior of aged A53T α-Synuclein Parkinson mice
Novel immunotherapeutic approaches to target alpha-synuclein and related neuroinflammation in Parkinson’s disease
Neuroinvasion and cerebral ischemia as possible sources for α-synuclein prions in Parkinson’s disease
Increased immune activation by pathologic α‐synuclein in parkinson's disease
Increased immune activation by pathologic α‐synuclein in Parkinson's disease
Cross-talk between α-synuclein post-translational modifications in yeast as model of Parkinson’s disease
Investigating the interplay between α-Synuclein and fragile X mental retardation protein in Parkinson’s disease
C-terminal tyrosine residue modifications modulate α-synuclein toxicity in yeast as unicellular model for Parkinson´s disease